In this video from Motley Fool Live recorded on Nov. 12, Henry Ji, chairman, president, and CEO of Sorrento Therapeutics (NASDAQ: SRNE), highlights what investors should expect from the biotech's...
- 2 min
- Brian Orelli, PhD
Begin Again (Korean: 비긴어게인) is a South Korean television program which airs on JTBC. Season 1 aired on Sundays at 22:30 (KST) beginning June 25 till September 10, 2017. Season 2 aired on Fridays at 21:20 (KST) beginning March 30 till June 29, 2018. 
Sorrento Therapeutics' CEO Henry Ji on the Status of the Company's 3 COVID-19 Tests | The Motley... The Motley Fool · 2 days ago. Fool Live recorded on Nov. 12, Sorrento Therapeutics' (NASDAQ:SRNE) chairman, president, and CEO ...regulatory affairs Mark Brunswick discuss the company's ...
SRNE Chief Executive Henry Ji told Fox News the antibody drug his company has produced can provide “100 per cent inhibition” of Covid-19. “We want to emphasise there is a cure,” he said.
Dr. Henry Ji To Participate In The H.C. Wainwright Bioconnect 2021 Virtual Investor Conference TheStreet.com · 1 day ago. SAN DIEGO, Jan. 10, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will
"We see high potential value for this new small molecule inhibitor of SARS-CoV-2 either as a standalone therapeutic or used in conjunction with the proprietary neutralizing antibodies (nAbs) STI-1499 and affinity matured STI-2020 being developed by our Company," according to Dr. Henry Ji, Sorrento's Chairman and CEO.
Recent executive movements at Sorrento Therapeutics. Edgar Lee has joined the company as Director (news posted on December 3 2020). Najjam Asghar, who was Chief Financial Officer, is promoted to Senior Vice President and Chief Financial Officer (news posted on December 3 2020).
There is a solution that works 100 percent,” Dr. Henry Ji, founder and CEO of Sorrento Therapeutics, told Fox News. “If we have the neutralizing antibody in your body, you don’t need the social distancing. You can open up a society without fear.” Sorrento Theraputics’ own website offers more information:
SORRENTO THERAPEUTICS, INC. DUNS: 832545805 CAGE Code: 5SPZ9 Status: Active 9380 Judicial Dr San Diego, CA, 92121-3830 , UNITED STATES
Douglas J. Langston is Former Chief Accounting Officer at Sorrento Therapeutics, Inc. View Douglas J. Langston’s professional profile on Relationship Science, the database of decision makers.